ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: PAs Available.

January 28, 2005

HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing

November 19, 1993

NCI-Approved Clinical Trials

September 28, 2001

In Brief: white House Names Phillip Sharp To NCAB; Shine Re-appointed As IOM President

September 27, 1996

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999